Journal of Drug Research in Ayurvedic Sciences

Register      Login

VOLUME 3 , ISSUE 1 ( 2018 ) > List of Articles

ORIGINAL RESEARCH

Micropropagation of Dhumrapatra (Aristolochia bracteolata Lam.): An Important Medicinal Plant of Ayurveda

Ritu Sinha, Gajendra Rao

Keywords : Conservation, Dhumrapatra, Hormones, In vitro, Regeneration.

Citation Information : Sinha R, Rao G. Micropropagation of Dhumrapatra (Aristolochia bracteolata Lam.): An Important Medicinal Plant of Ayurveda. J Drug Res Ayurvedic Sci 2018; 3 (1):9-14.

DOI: 10.5005/jp-journals-10059-0030

License: CC BY-NC-SA 3.0

Published Online: 00-03-2018

Copyright Statement:  Copyright © 2018; Jaypee Brothers Medical Publishers (P) Ltd.


Abstract

Aim: Dhumrapatra is an important medicinal plant used in Indian system of medicine. Due to overexploitation and unsystematic collection, it is becoming rare and endangered in some parts of India. To meet the demand of the authentic drug and propagate the plant on a large scale, an in vitro propagation technique has been developed for Dhumrapatra. Materials and methods: The collected plant was identified with the help of floras. Murashige and Skoog basal (MS) medium was prepared as per the standard protocol. Surface sterilization of explants was done with the help of disinfectant and 0.1% solution of HgCl2. Media were autoclaved at 121°C under 15 lb/inch2 pressure for 15 minutes. Cultures were incubated at 22°C ± 2°C and 8 hours photoperiod with light intensity of 3000 lux. Observations were recorded after a 4-week period. Results: Best establishment of shoots (20 nos.) was found in MS media augmented with 0.5 mg/L kinetin (Kn). Maximum roots (2–3 nos) produced in MS were fortified with 3 mg/L indolebutyric acid (IBA). Maximum number of shoots and roots were achieved on nodal explants inoculated on MS + Kn (0.5 mg/L) + 0.1% polyvinylpyrrolidone (PVP). Conclusion: The in vitro propagation protocol developed for Dhumrapatra would be beneficial for rapid multiplication and conservation of important medicinal plant.


PDF Share
  1. The Plant List. A working list for all plant species. 2013. [cited 2013 Jan 1]. Available from: http://www.theplantlist.org/.
  2. Cooke, T. The flora of the presidency of Bombay. 2nd Reprint. Vol. 3. Calcutta: Botanical Survey of India; 1967. p. 16.
  3. Kirtikar, KR.; Basu, BD. Indian medicinal plants. Vol. 3. Dehradun: Bishensingh Mahendra Pal Singh; 1988. p. 2480.
  4. Naik, VN. Flora of Marathwada. Vol. 2. Aurangabad: Amrut Prakashan; 1998. p. 766.
  5. Singh, NP.; Lakshminarasimhan, P.; Karthikeyan, S.; Prasanna, PV. Flora of Maharashtra state—dicotyledones. Vol. 2. Calcutta: Botanical Survey of India; 2001. p. 814.
  6. Negi PS, Anantharamakrishnan C, Jayaprakasha GK. Antibacterial activity of Aristolochia bracteolata roots extracts. J Med Food 2003 Winter;6(4):401-403.
  7. Anonymous. The ayurvedic pharmacopoeia of India. Part 1. Vol. 6. New Delhi: The Controller of Publications, Ministry of Health and Family Welfare, Dept. of ISM&H, Govt. of India; 2008. p. 88.
  8. Udhaya Nandhini D, Rajasekar M, Venmathi T. A review on worm killer: Aristolochia bracteolata. J Pharmacogn Phytochem 2017 Feb;6(2):6-9.
  9. Thirumal M, Vadivelan R, Kishore G, Brahmaji VS. Aristolochia bracteolata: an overview on pharmacognostical, phytochemical and pharmacological properties. Crit Rev Pharm Sci 2012;1(1):70-82.
  10. Bharathajothi P, Bhaskaran CT. Phytochemical and pharmacological evaluations of Aristolochia bracteolata Lam. Asian J Plant Sci Res 2014;4(6):15-19.
  11. Rao, RR.; Sharma, BD. A manual for herbarium collections. Calcutta: Botanical Survey of India; 1990. p. 5-20.
  12. Murashige T, Skoog F. A revised medium for rapid growth and bio assays with tobacco tissue culture. Physiol Plant 1962 Jul;15(3):473-497.
  13. Abu-Romman SM, Al-Hadid KA, Arabiyyat AR. Kinetin is the most effective cytokinin on shoot multiplication from Cucumber. J Agric Sci 2015 Sep;7(10):159-165.
  14. Sebastinraj J, Inayath Sidique KM. In vitro rapid clonal propagation of Aristolochia bracteolata Lam. (Aristolochiaceae)— a valuable medicinal plant. World J Agric Sci 2011;7(6): 653-658.
  15. Sahaya Sathish S, Janakiraman N, Johnson M. In vitro propagation of Aristolochia bracteata Retz—a medicinally important plant. Res Biotechnol 2011 Jan;2(6):44-52.
  16. Chandra Prabha A, Rama Subbu R, Kulloli SK. Micropropagation of Aristolochia indica L. (Aristolochiaceae). Ecol Environ Conserv 2008 Jan;14(2-3):409-411.
  17. Sarma B, Tanti B. In vitro regeneration of plantlets from nodal explants of Aristolochia saccata and Aristolochia cathcartii. Eur J Biol Res 2017;7(3):191-201.
  18. Biswas A, Bari MA, Roy M, Bhadra SK. In vitro regeneration of Aristolochia tagala Champ—a rare medicinal plant of Chittagong hill tracts. J Bio-Sci 2007;15:63-67.
  19. Lavanya A, Ambikapathy V, Panneerselvam A. Effective in vitro propagation of Medicinally valuable plant—Aristolochia bracteolate Lam. Int J Curr Res 2016 May;8(5):30242-30244.
  20. Pinto Lde R, Acosta EJ, Távora FF, da Silva PM, Porto VC. Effect of repeated cycles of chemical disinfection on the roughness and hardness of hard reline acrylic resins. Gerodontology 2010 Jun;27(2):147-153.
  21. Regis RR, Zanini AP, Della Vecchia MP, Silva-Lovato CH, Oliveira Paranhos HF, de Souza RF. Physical properties of an acrylic resin after incorporation of an antimicrobial monomer. J Prosthodont 2011 Jul;20(5):372-379.
  22. Yusuf M, Ahmad A, Shahid M, Khan MI, Khana SA, Manzoor N, Mohammad F. Assessment of colorimetric, antibacterial and antifungal properties of woollen yarn dyed with the extract of the leaves of henna (Lawsonia inermis). J Clean Prod 2012 May;27:42-50.
  23. Kolenbrander PE, Andersen RN, Blehert DS, Egland PG, Foster JS, Palmer RJ Jr. Communication among oral bacteria. Microbiol Mol Biol Rev 2002 Sep;66(3):486-505.
  24. Cunha TR, Regis RR, Bonatti MR, de Souza RF. Influence of incorporation of fluoroalkyl methacrylates on roughness and flexural strength of a denture base acrylic resin. Appl Oral Sci 2009 Mar-Apr;17(2):103-107.
  25. Zamperini CA, Machado AL, Vergani CE, Pavarina AC, Giampaolo ET, da Cruz NC. Adherence in vitro of Candida albicans to plasma treated acrylic resin. Effect of plasma parameters, surface roughness and salivary pellicle. Arch Oral Biol 2010 Oct;55(10):763-770.
  26. Verran J, Maryan CJ. Retention of Candida albicans on acrylic resin and silicone of different surface topography. J Prosthet Dent 1997 May;77(5):535-539.
  27. Radford DR, Sweet SP, Challacombe SJ, Walter JD. Adherence of Candida albicans to denture-base materials with different surface finishes. J Dent 1998 Sep;26(7):577-583.
  28. Consani RL, Folli BL, Nogueira MC, Correr AB, Mesquita MF. Effect of polymerization cycles on gloss, roughness, hardness and impact strength of acrylic resins. Braz Dent J 2016 Mar-Apr;27(2):176-180.
  29. Arora P, Singh SP, Arora V. Effect of alumina addition on properties of poly-methyl methacrylate-a comprehensive review. Int J Biotech Trends Technol 2015 Jan-Mar;5(1):1-7.
  30. Bollen CM, Lambrechts P, Quirynen M. Comparison of surface roughness of oral hard materials to the threshold surface roughness for bacterial plaque retention: a review of the literature. Dent Mater 1997 Jul;13(4):258-269.
  31. Zissis AJ, Polyzois GL, Yannikakis SA, Harrison A. Roughness of denture materials: a comparative study. Int J Prosthodont 2000 Mar-Apr;13(2):136-140.
  32. Moura JS, da Silva WJ, Pereira T, Del Bel Cury AA, Rodrigues Garcia RC. Influence of acrylic resin polymerization methods and saliva on the adherence of four Candida species. J Prosthet Dent 2006 Sep;96(3):205-211.
  33. de Castro RD, Mota AC, de Oliveira Lima E, Batista AU, de Araújo Oliveira J, Cavalcanti AL. Use of alcohol vinegar in the inhibition of Candida spp. and its effect on the physical properties of acrylic resins. BMC Oral Health 2015 Apr;15:52.
  34. Azevedo A, Machado AL, Vergani CE, Giampaolo ET, Pavarina AC. Hardness of denture base and hard chair-side reline acrylic resins. J Appl Oral Sci 2005 Sep;13(3):291-295.
  35. Faltermeier A, Rosentritt M, Müssig D. Acrylic removable appliances: comparative evaluation of different post-polymerization methods. Am J Orthod Dentofacial Orthop 2007 Mar;131(3):301.e16-301.e22.
  36. Aydogan Ayaz E, Durkan R, Bagis B. The effect of acrylamide incorporation on the thermal and physical properties of denture resins. J Adv Prosthodont 2013 May;5(2):110-117.
  37. Kati FA, Al-Kaabi AF. Effect of oil paint addition on micro hardness of acrylic ocular prosthesis. Iraq Dent J 2016 Aug;38(2): 87-89.
  38. Faraji G, Asadi P. Characterization of AZ91/alumina nanocomposite produced by FSP. Mater Sci Eng A 2011 Mar;528(6): 2431-2440.
  39. Köroðlu A, Þahin O, Kürkçüoðlu I, Dede DO, Özdemir T, Hazer B. Silver nanoparticle incorporation effect on mechanical and thermal properties of denture base acrylic resins. J Appl Oral Sci 2016 Nov-Dec;24(6):590-596.
  40. Gad MM, Al-Thobity AM, Shahin SY, Alsaqer BT, Ali AA. Inhibitory effect of zirconium oxide nanoparticles on Candida albicans adhesion to repaired polymethyl methacrylate denture bases and interim removable prostheses: a new approach for denture stomatitis prevention. Int J Nanomedicine 2017 Jul;28(12): 5409-5419.
  41. Sundareswaran S, Ramakrishnan R. The Facial Aesthetic index: An additional tool for assessing treatment need. J Orthod Sci 2016;5:57-63.
  42. Schabel BJ, McNamara JA Jr, Franchi L, Baccetti T. Q-sort assessment vs visual analog scale in the evaluation of smile esthetics. Am J Orthod Dentofacial Orthop 2009 Apr;135 (4 Suppl):S61-S71.
  43. Mergen JL, Southard KA, Dawson DV, Fogle LL, Casko JS, Southard TE. Treatment outcomes of growing Class II Division 1 patients with varying degrees of anteroposterior and vertical dysplasias, Part 2. Profile silhouette evaluation. Am J Orthod Dentofacial Orthop 2004 Apr;125(4):457-462.
  44. Sloss EA, Southard KA, Qian F, Stock SE, Mann KR, Meyer DL, Southard TE. Comparison of soft-tissue profiles after treatment with headgear or Herbst appliance. Am J Orthod Dentofacial Orthop 2008 Apr;133(4):509-514.
  45. Mann KR, Marshall SD, Qian F, Southard KA, Southard TE. Effect of maxillary anteroposterior position on profile esthetics in headgear-treated patients. Am J Orthod Dentofacial Orthop 2011 Feb;139(2):228-234.
  46. Hockley A, Weinstein M, Borislow AJ, Braitman LE. Photos vs silhouettes for evaluation of African American profile esthetics. Am J Orthod Dentofacial Orthop 2012 Feb;141(2): 161-168.
  47. Tehranchi A, Saedi S, Motamedian SR, Rohani K. Radiographic evaluation of frontal sinus dimensions and anatomic variations. Br J Med Med Res 2015 May;8(5):454-462.
  48. Tehranchi A, Motamedian SR, Saedi S, Kabiri S, Shidfar S. Correlation between frontal sinus dimensions and cephalometric indices: a cross-sectional study. Eur J Dent 2017 Jan-Mar;11(1):64-70.
  49. World Health Organization. WHOQOL-BREF: introduction, administration, scoring and generic version of the assessment: field trial version, december 1996. Geneva; 1996.
  50. Deshpande S, Nagendra HR, Raghuram N, et al. A randomized control trial of the effect of yoga on Gunas (personality) and Health in normal healthy volunteers. Int J Yoga 2008 Jan;1(1):2-10.
  51. Patra S, Telles S, et al. Positive impact of cyclic meditation on subsequent sleep. Med Sci Monit 2009 Jul;15(7):CR375-81.
  52. Hegde A, Metri K, Chwadhary P, Babu N, Nagendra HR, et al. Effects of yoga on cardiac health sleep quality, mental health and quality of life of elderly individuals with chronic ailments. Voice Res. 2017;6(1):1-5.
  53. Splinter MY. Rotigotine: transdermal dopamine agonist treatment of Parkinson's disease and restless legs syndrome. Ann Pharmacother 2007 Feb;41(2):285-295.
  54. Iranzo A, Molinuevo JL, Santamaría J, Serradell M, Martí MJ, Valldeoriola F, Tolosa E. Rapid-eye-movement sleep behaviour disorder as an early marker for a neurodegenerative disorder: a descriptive study. Lancet Neurol 2006 Jul;5(7):572-577.
  55. Howell MJ, Schenck CH. Rapid eye movement sleep behavior disorder and neurodegenerative disease. JAMA Neurol 2015 Jun;72(6):707-712.
  56. Sixel-Döring F, Trautmann E, Mollenhauer B, Trenkwalder C. Rapid eye movement sleep behavioral events: a new marker for neurodegeneration in early Parkinson disease? Sleep 2014 Mar;37(3):431-438.
  57. Vibha D, Shukla G, Goyal V, Singh S, Srivastava AK, Behari M. RBD in Parkinson's disease: a clinical case control study from North India. Clin Neurol Neurosurg 2011 Jul;113(6):472-476.
  58. Vibha D, Shukla G, Singh S, Goyal V, Srivastava AK, Behari M. Lower prevalence of sleep disturbances in familial versus sporadic Parkinson's disease: a questionnaire based study. J Neurol Sci 2010 Aug;295(1-2):27-30.
  59. Abu Alhaija ES, Al-Nimri KS, Al-Khateeb SN. Self perception of malocclusion among Jordanian school children. Eur J Orthod 2005 Jun;27(3):292-295.
  60. Kolawole KA, Otuyemi DE, Jebode SO, Unweni AA. Awareness for malocclusion and desire for orthodontic treatment need in 11-14year old Nigerian school and their parents. Aust Orthod J 2008 May;24(1):21-25.
  61. Cucalon A 3rd, Smith RJ. Relationship between by adolescent orthodontics patients and performance on psychological tests. Angle Orthod 1990 Summer;60(2):107-114.
  62. Southard KA, Tolley EA, Arheart KL, Hackett-Renner CA, Southard TE. Application of the Millon Adolescent Personality Inventory in evaluating orthodontic compliance. Am J Orthod Dentofacial Orthop 1991 Dec;100(6):553-561.
  63. Kharbanda OP. What is the prevalence of malocclusion in India? Do we know orthodontic treatment needs of our country. J Indian Orthod Soc 1999 Apr-Jun;32(2):33-41.
  64. Siddiqui TA, Shaikh A, Fida M. Agreement between orthodontist and patient perception using Index of Orthodontic Treatment Need. Saudi Dent J 2014 Oct;26(4):156-165.
  65. Borzabadi-Farahani A, Borzabadi-Farahani A, Eslamipour F. Orthodontic treatment needs in an urban Iranian population in epidemiological study of 11-14 years old children. Eur J Paediatr Dent 2009 Jun;10(2):69-74.
  66. Grando G, Young AA, Vedovello Filho M, Vedovello SA, Ramirez-Yañez GO. Prevalence of malocclusions in a young Brazilian population. Int J Orthod Milwaukee 2008 Summer;19(2):13-16.
  67. Nadim R, Aslam K, Rizwan S. Frequency of malocclusion among 12 -15 years old school children in three sectors of Karachi. Pak Oral Dent J 2014 Sep;34(3):510-514.
  68. Reddy ER, Manjula M, Sreelakshmi N, Rani ST, Aduri R, Patil BD. Prevalence of malocclusion among 6 to 10 year old Nalgonda school children. J Int Oral Health 2013 Dec;5(6): 49-54.
  69. Onyeaso CO. Prevalence of malocclusion among adolescents in Ibadan, Nigeria. Am J Orthod Dentofacial Orthop 2004 Nov;126(5):604-607.
  70. Kaur H, Pavithra US, Abraham R. Prevalence of malocclusion among adolescents in South Indian population. J Int Soc Prev Community Dent 2013 Jul-Dec;3(2):97-102.
  71. Lauc T. Orofacial analysis on the Adriatic islands: an epidemiological study of malocclusions on Hvar Island. Eur J Orthod 2003 Jun;25(3):273-278.
  72. Zimmermann E, Gamborg M, Holst C, Baker JL, Sørensen TI, Berentzen TL. Body mass index in school-aged children and the risk of routinely diagnosed non-alcoholic fatty liver disease in adulthood: a prospective study based on the Copenhagen School Health Records Register. BMJ Open 2015 May;5(4):e006998.
  73. Singh SP. Non-alcoholic fatty liver disease: the unfolding monster? J Gastroenterol Hepatol 2006 Jan;21(1 Pt 2):199-201.
  74. Reece EA, Hagay Z, Roberts AB, DeGennaro N, Homko CJ, Connolly-Diamond M, Sherwin R, Tamborlane WV, Diamond MP. Fetal Doppler and behavioral responses during hypoglycemia induced with the insulin clamp technique in pregnant diabetic women. Am J Obstet Gynecol 1995 Jan;172(1 Pt 1):151-155.
  75. Patrick J, Campbell K, Carmichael L, Natale R, Richardson B. Patterns of gross fetal body movements over 24-hour observation intervals during the last 10 weeks of pregnancy. Am J Obstet Gynecol 1982 Feb;142(4):363-371.
  76. Ornoy A, Ratzon N, Greenbaum C, Peretz E, Soriano D, Dulitzky M. Neurobehavior of school age children born to diabetic mothers. Arch Dis Child Fetal Neonatal Ed 1998 Sep;79(2):F94-F99.
  77. Wolf, A. Developmental evaluation on early school age children born to gestational diabetic mothers. Israel: Hebrew University; 1997.
  78. Mulder EJ, Leiblum DM, Visser GH. Fetal breathing movements in late diabetic pregnancy: relationship to fetal heart rate patterns and Braxton Hicks’ contractions. Early Hum Dev 1995 Nov;43(3):225-232.
  79. Schulte FJ, Michaelis R, Nolte R, Albert G, Parl U, Lasson U. Brain and behavioral maturation in newborn infants of diabetic mothers. I. Nerve conduction and EEG patterns. Neuropadiatrie 1969 Jan-Jul;1(1):24-35.
  80. Devoe LD, Youssef AA, Castillo RA, Croom CS. Fetal biophysical activities in third-trimester pregnancies complicated by diabetes mellitus. Am J Obstet Gynecol 1994 Aug;171(2):298-303.
  81. Dierker LJ Jr, Pillay S, Sorokin Y, Rosen MG. The change in fetal activity periods in diabetic and nondiabetic pregnancies. Am J Obstet Gynecol 1982 May;143(2):181-185.
  82. Doherty NN, Hepper PG. Habituation in fetuses of diabetic mothers. Early Hum Dev 2000 Aug;59(2):85-93.
  83. Kainer F, Prechtl HF, Engele H, Einspieler C. Assessment of the quality of general movements in fetuses and infants of women with type-1 diabetes mellitus. Early Hum Dev 1997 Nov;50(1):13-25.
  84. Mulder EJ, O'Brien MJ, Lems YL, Visser GH, Prechtl HF. Body and breathing movements in near-term fetuses and newborn infants of type-1 diabetic women. Early Hum Dev 1990 Nov;24(2):131-152.
  85. Mulder EJ, Visser GH. Growth and motor development in fetuses of women with type-1 diabetes. I. Early growth patterns. Early Hum Dev 1991 May;25(2):91-106.
  86. Mulder EJ, Visser GH. Growth and motor development in fetuses of women with type-1 diabetes. II. Emergence of specific movement patterns. Early Hum Dev 1991 May;25(2):107-115.
  87. Mulder EJ, Visser GH. Impact of early growth delay on subsequent fetal growth and functional development: a study on diabetic pregnancy. Early Hum Dev 1992 Dec;31(2):91-95.
  88. Mulder EJ, Visser GH, Bekedam DJ, Prechtl HF. Emergence of behavioral states in fetuses of type-1 diabetic women. Early Hum Dev 1987 Jul;15(4):231-251.
  89. Mulder EJ, Visser GH, Morssink LP, de Vries JI. Growth and motor development in fetuses of women with type-1 diabetes. III. First trimester quantity of fetal movement patterns. Early Hum Dev 1991 May;25(2):117-133.
  90. Aberg A, Westbom L, Kallen B. Congenital malformations among infants whose mothers had gestational diabetes or preexisting diabetes. Early Hum Dev 2001 Mar;61(2):85-95.
  91. Deregnier RA, Nelson CA, Thomas KM, Wewerka S, Georgieff MK. Neurophysiologic evaluation of auditory recognition memory in healthy newborn infants and infants of diabetic mothers. J Pediatr 2000 Dec;137(6):777-784.
  92. Nelson CA, Wewerka S, Thomas KM, Tribby-Walbridge S, deRegnier R, Georgieff M. Neurocognitive sequelae of infants of diabetic mothers. Behav Neurosci 2000 Oct;114(5):950-956.
  93. Reece EA, Homko CJ. Infant of the diabetic mother. Semin Perinatol 1994 Oct;18(5):459-469.
  94. Reece EA, Homko CJ. Why do diabetic women deliver malformed infants? Clin Obstet Gynecol 2000 Mar;43(1):32-45.
  95. Rizzo T, Metzger BE, Burns WJ, Burns K. Correlations between antepartum maternal metabolism and intelligence of offspring. N Engl J Med 1991 Sep;325(13):911-916.
  96. Rizzo TA, Metzger BE, Dooley SL, Cho NH. Early malnutrition and child neurobehavioral development: insights from the study of children of diabetic mothers. Child Dev 1997 Feb;68(1):26-38.
  97. Schwartz R, Teramo KA. Effects of diabetic pregnancy on the fetus and newborn. Semin Perinatol 2000 Apr;24(2):120-135.
  98. Vaarasmaki MS, Hartikainen A, Anttila M, Pramila S, Koivisto M. Factors predicting peri- and neonatal outcome in diabetic pregnancy. Early Hum Dev 2000 Jul;59(1):61-70.
  99. Robertson SS, Dierker LJ. Fetal cyclic motor activity in diabetic pregnancies: sensitivity to maternal blood glucose. Dev Psychobiol 2003 Jan;42(1):9-16.
  100. Accardo PJ, Blondis TA, Whitman BY. Disorders of attention and activity level in a referral population. Pediatrics 1990 Mar;85(3 Pt 2):426-431.
  101. Ornoy A, Uriel L, Tennenbaum A. Inattention, hyperactivity and speech delay at 2-4 years of age as a predictor for ADDADHD syndrome. Isr J Psychiatry Relat Sci 1993;30(3):155-163.
  102. Smyth TR. Impaired motor skill (clumsiness) in otherwise normal children: a review. Child Care Health Dev 1992 Sep-Oct;18(5):283-300.
  103. Petersen MB, Pedersen SA, Greisen G, Pedersen JF, Mølsted- Pedersen L. Early growth delay in diabetic pregnancy: relation to psychomotor development at age 4. Br Med J (Clin Res Ed) 1988 Feb;296(6622):598-600.
  104. Sells CJ, Robinson NM, Brown Z, Knopp RH. Long-term developmental follow-up of infants of diabetic mothers. J Pediatr 1994 Jul;125(1):S9-S17.
  105. Vladareanu R, Lebit D, Constantinescu S. Ultrasound assessment of fetal neurobehaviour in high risk pregnancies. DSJUOG 2012 Apr-Jun;6(2):132-147.
  106. Talic A, Kurjak A, Ahmed B, Stanojevic M, Predojevic M, Kadic AS, Di Renzo GC. The potential of 4D sonography in the assessment of fetal behavior in high-risk pregnancies. J Matern Fetal Neonatal Med 2011 Jul;24(7):948-954.
  107. Bekedam DJ, Visser GH, de Vries JJ, Prechtl HF. Motor behaviour in the growth retarded fetus. Early Hum Dev 1985 Nov;12(2):155-165.
  108. Cioni G, Prechtl HF. Preterm and early postterm motor behaviour in low-risk premature infants. Early Hum Dev 1990 Sep;23(3):159-191.
  109. Seme-Ciglenecki P. Predictive value of assessment of general movements for neurological development of highrisk preterm infants: comparative study. Croat Med J 2003 Dec;44(6):721-727.
  110. Abo-Yaqoub S, Kurjak A, Mohammed AB, Shadad A, Abdel-Maaboud M. The role of 4-D ultrasonography in prenatal assessment of fetal neurobehaviour and prediction of neurological outcome. J Matern Fetal Neonatal Med 2012 Mar;25(3):231-236.
  111. Athanasiadis AP, Mikos T, Tambakoudis GP, Theodoridis TD, Papastergiou M, Assimakopoulos E, Tarlatzis BC. Neurodevelopmental fetal assessment using KANET scoring system in low and high-risk pregnancies. J Matern Fetal Neonatal Med 2013 Mar;26(4):363-368.
  112. Fauser BC, Tarlatzis BC, Rebar RW, Legro RS, Balen AH, Lobo R, Carmina E, Chang J, Yildiz BO, Laven JS, et al. Consensus on women's health aspects of polycystic ovary syndrome (PCOS): the Amsterdam ESHRE/ASRM-Sponsored 3rd PCOS Consensus Workshop Group. Fertil Steril 2012 Jan;97(1):28-38.e25
  113. Sirmans SM, Pate KA. Epidemiology, diagnosis and management of polycystic ovary syndrome. Clin Epidemiol 2014; 6:1-13.
  114. Fauser BC, Diedrich K, Bouchard P, Domínguez F, Matzuk M, Franks S, Hamamah S, Simón C, Devroey P, Ezcurra D, et al. Contemporary genetic technologies and female reproduction. Human Reproduction Update 2011 Nov;17(6):829-847.
  115. Balen A, Conway G, Kaltsas G. Polycystic ovary syndrome: the spectrum of the disorder in 1741 patients. Hum Reprod 1995 Aug;10(8):2107-2111.
  116. Azziz R, Sanchez L, Knochenhauer ES, Moran C, Lazenby J, Stephens KC, Taylor K, Boots LR. Androgen excess in women: experience with over 1000 consecutive patients. J Clin Endocrinol Metab 2004 Feb;89(2):453-462.
  117. Wild S, Pierpoint T, McKeigue P, Jacobs H. Cardiovascular disease in women with polycystic ovary syndrome at longterm follow-up: a retrospective cohort study. Clin Endocrinol (Oxf) 2000 May;52(5):595-600.
  118. Hollinrake E, Abreu A, Maifeld M, Van Voorhis BJ, Dokras A. Increased risk of depressive disorders in women with polycystic ovary syndrome. Fertil Steril 2007 Jun;87(6): 1369-1376.
  119. Zawadski JK, Dunaif A. Diagnostic criteria for polycystic ovary syndrome. In: Givens JHF, Merriman G, editors. The polycystic ovary syndrome. Cambridge, MA: Blackwell Scientific; 1992. p. 377-384.
  120. Rotterdam ESHRE/ASRM-Sponsored PCOS Consensus Workshop Group. Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome. Fertil Steril 2004 Jan;81(1):19-25.
  121. Azziz R, Carmina E, DeWailly D, Diamanti-Kandarakis E, Escobar-Morreale HF, Futterweit W, Janssen OE, Legro RS, Norman RJ, Taylor AE, et al. Position statement: criteria for defining polycystic ovary syndrome as a predominantly hyperandrogenic syndrome: an Androgen Excess Society guideline. J Clin Endocrinol Metab 2006 Nov;91(11):4237-4245.
  122. Lujan ME, Jarrett BY, Brooks ED, Reines JK, Peppin AK, Muhn N, Haider E, Pierson RA, Chizen DR. Updated ultrasound criteria for polycystic ovary syndrome: reliable thresholds for elevated follicle population and ovarian volume. Hum Reprod 2013 May;28(5):1361-1368.
  123. Badawy A, Elnashar A. Treatment options for polycystic ovary syndrome. Int J Womens Health 2011 Feb;3:25-35.
  124. ACOG Committee on Practice Bulletins—Gynecology. ACOG Practice Bulletin No 108: Polycystic ovary syndrome. Obstet Gynecol 2009 Oct;114(4):936-949.
  125. Thessaloniki ESHRE/ASRM-Sponsored PCOS Consensus Workshop Group Consensus on infertility treatment related to polycystic ovary syndrome. Fertil Steril 2008 Mar;89(3): 505-522.
  126. Balen AH. Ovulation induction in the management of anovulatory polycystic ovary syndrome. Mol Cell Endocrinol 2013 Jul;373(1-2):77-82.
  127. Berridge DL, Winter TC. Saline infusion sonohysterography: technique, indications, and imaging findings. J Ultrasound Med 2004 Jan;23(1):97-112.
  128. Allison SJ, Horrow MM, Kim HY, Lev-Toaff AS. Salineinfused sonohysterography: tips for achieving greater success. Radiographics 2011 Nov-Dec;31(7):1991-2004.
  129. O'Neill MJ. Sonohysterography. Radiol Clin North Am 2003 Jul;41(4):781-797.
  130. Bonnamy L, Marret H, Perrotin F, Body G, Berger C, Lansac J. Sonohysterography: a prospective survey of results and complications in 81 patients. Eur J Obstet Gynecol Reprod Biol 2002 Apr;102(1):42-47.
  131. Lindheim SR, Adsuar N, Kushner DM, Pritts EA, Olive DL. Sonohysterography: a valuable tool in evaluating the female pelvis. Obstet Gynecol Surv 2003 Nov;58(11):770-784.
  132. Lindheim SR, Sprague C, Winter TC. Hysterosalpingography and sonohysterography: lessons in technique. AJR Am J Roentgenol 2006 Jan;186(1):24-29.
  133. Jeanty P, Besnard S, Arnold A, Turner C, Crum P. Air-contrast sonohysterography as a first step assessment of tubal patency. J Ultrasound Med 2000 Aug;19(8):519-527.
PDF Share